DK0750502T3 - Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier - Google Patents

Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier

Info

Publication number
DK0750502T3
DK0750502T3 DK95911149T DK95911149T DK0750502T3 DK 0750502 T3 DK0750502 T3 DK 0750502T3 DK 95911149 T DK95911149 T DK 95911149T DK 95911149 T DK95911149 T DK 95911149T DK 0750502 T3 DK0750502 T3 DK 0750502T3
Authority
DK
Denmark
Prior art keywords
pct
endocrinopathies
alkaloids
treatment
phosphorus derivatives
Prior art date
Application number
DK95911149T
Other languages
Danish (da)
English (en)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Application granted granted Critical
Publication of DK0750502T3 publication Critical patent/DK0750502T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK95911149T 1994-03-18 1995-03-20 Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier DK0750502T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0057894A AT407608B (de) 1994-03-18 1994-03-18 Mittel zur behandlung von osteoporose
PCT/AT1995/000055 WO1995025522A1 (fr) 1994-03-18 1995-03-20 Utilisation de derives phosphoriques d'alcaloïdes pour le traitement d'endocrinopathies

Publications (1)

Publication Number Publication Date
DK0750502T3 true DK0750502T3 (da) 2001-08-06

Family

ID=3494294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95911149T DK0750502T3 (da) 1994-03-18 1995-03-20 Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier

Country Status (15)

Country Link
US (1) US5888991A (fr)
EP (1) EP0750502B1 (fr)
JP (1) JP4130473B2 (fr)
AT (2) AT407608B (fr)
AU (1) AU690232B2 (fr)
CA (1) CA2180717C (fr)
CZ (1) CZ290669B6 (fr)
DE (1) DE59509229D1 (fr)
DK (1) DK0750502T3 (fr)
ES (1) ES2158089T3 (fr)
GR (1) GR3036205T3 (fr)
NZ (1) NZ281889A (fr)
PT (1) PT750502E (fr)
SK (1) SK282103B6 (fr)
WO (1) WO1995025522A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
AT518206A2 (de) 2016-01-29 2017-08-15 Neovia Proteinkinase-C-Inhibitor enthaltender Tierfutterzusatz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT354644B (de) * 1975-12-19 1980-01-25 Nowicky Wassili Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) * 1976-06-28 1985-05-28 Nowicky Wassili Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
GB2110553A (en) * 1981-12-01 1983-06-22 Willett And Company Limited Th Pressurized filtration system
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4735945A (en) * 1986-03-13 1988-04-05 Vipont Laboratories, Inc. Method for inhibiting bone resorption and collagenase release
EP0326627A1 (fr) * 1988-02-01 1989-08-09 Vipont Pharmaceutical, Inc. Méthode pour l'inhibition de résorption d'os et libération de collagénase

Also Published As

Publication number Publication date
CA2180717A1 (fr) 1995-09-28
ATA57894A (de) 2000-09-15
DE59509229D1 (de) 2001-06-07
PT750502E (pt) 2001-09-28
WO1995025522A1 (fr) 1995-09-28
US5888991A (en) 1999-03-30
NZ281889A (en) 1997-04-24
SK282103B6 (sk) 2001-11-06
CZ290669B6 (cs) 2002-09-11
EP0750502B1 (fr) 2001-05-02
CA2180717C (fr) 1999-12-07
ES2158089T3 (es) 2001-09-01
JPH09510459A (ja) 1997-10-21
AU690232B2 (en) 1998-04-23
EP0750502A1 (fr) 1997-01-02
ATE200865T1 (de) 2001-05-15
GR3036205T3 (en) 2001-10-31
AU1884895A (en) 1995-10-09
SK118496A3 (en) 1997-05-07
CZ264596A3 (en) 1996-12-11
JP4130473B2 (ja) 2008-08-06
AT407608B (de) 2001-05-25

Similar Documents

Publication Publication Date Title
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
EE200000318A (et) Uudsed ühendid
IL127598A0 (en) A process for preparing iso-taxol analogs
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
HK1014440A1 (en) Trisubstituted phenyl derivatives
ZA987140B (en) Treatment of attention deficit disorders
TR199901104T2 (xx) Farmas�tik bile�ikler.
IL115184A (en) Use of anthracycline derivatives for preparing medivaments for treating amyloidosis
DE60135752D1 (en) Tyrosinderivate als phosphatase inhibitoren
DK0750502T3 (da) Anvendelse af phosphorderivater af alkaloider til behandling af endokrinopatier
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására
SE9404438D0 (sv) New process
DK0766695T3 (da) Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme
ATE272651T1 (de) Verbindungen mit wachstumshormon-freisetzender eigenschaft
MX9603797A (es) Agentes terapeuticos para su uso en la terapia del cancer.
MX9705723A (es) Formulacion transdermica.